Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India

While Hepatitis A Virus (HAV) vaccination in global immunization programs has shown a virtual elimination of the disease within few years of the vaccination program, changing epidemiological landscape in India underscores the need for evidence-based, updated guidance on immunization practices. In Ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Nitin Shah, M.M.A. Faridi, Sheila Bhave, Apurba Ghosh, S. Balasubramanian, Vidya Arankalle, Raju Shah, Amar Jeet Chitkara, Arun Wadhwa, Jaydeep Chaudhry, Ramesh Srinivasan, M. Surendranath, Amita Sapru, Monjori Mitra
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2447643
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540524745064448
author Nitin Shah
M.M.A. Faridi
Sheila Bhave
Apurba Ghosh
S. Balasubramanian
Vidya Arankalle
Raju Shah
Amar Jeet Chitkara
Arun Wadhwa
Jaydeep Chaudhry
Ramesh Srinivasan
M. Surendranath
Amita Sapru
Monjori Mitra
author_facet Nitin Shah
M.M.A. Faridi
Sheila Bhave
Apurba Ghosh
S. Balasubramanian
Vidya Arankalle
Raju Shah
Amar Jeet Chitkara
Arun Wadhwa
Jaydeep Chaudhry
Ramesh Srinivasan
M. Surendranath
Amita Sapru
Monjori Mitra
author_sort Nitin Shah
collection DOAJ
description While Hepatitis A Virus (HAV) vaccination in global immunization programs has shown a virtual elimination of the disease within few years of the vaccination program, changing epidemiological landscape in India underscores the need for evidence-based, updated guidance on immunization practices. In May 2024, a panel of 15 distinguished opinion leaders and an organizing committee convened for an intensive, face-to-face advisory board meeting on high burden of HAV infection among adults, increased mortality rate in adolescents, symptomatic presentation in children, and evolving landscape globally and within India. Extensive comparable deliberations on long-term follow-up data from India and data from country of origin advocated immunogenicity, tolerability, and long-term protective effects of single-dose live attenuated HAV vaccine in children. Finally, a consensus was achieved on recognition of increased global attention toward HAV prevention through vaccination coverage. The need for a single dose of live attenuated HAV vaccine was an important outcome of this meeting.
format Article
id doaj-art-49d17eaccda54f6cb3d8a5fac5d97582
institution Kabale University
issn 2164-5515
2164-554X
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj-art-49d17eaccda54f6cb3d8a5fac5d975822025-02-04T20:10:42ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2025-12-0121110.1080/21645515.2024.2447643Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in IndiaNitin Shah0M.M.A. Faridi1Sheila Bhave2Apurba Ghosh3S. Balasubramanian4Vidya Arankalle5Raju Shah6Amar Jeet Chitkara7Arun Wadhwa8Jaydeep Chaudhry9Ramesh Srinivasan10M. Surendranath11Amita Sapru12Monjori Mitra13Department of Paediatrics, P. D. Hinduja Hospital & Medical Research Centre, Mumbai, IndiaDepartment of Paediatrics and Neonatology, Era’s Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh, IndiaDepartment of Paediatrics, KEM Hospital Research Centre, Pune, IndiaDepartment of Paediatrics, Institute of Child Health, Kolkata, IndiaDepartment of Pediatrics, Kanchi Kamakoti CHILDS Trust Hospital, Chennai, IndiaDepartment of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, IndiaDepartment of Pediatrics, Ankur Children Hospital, Ahmedabad, Gujarat, IndiaDepartment of Pediatrics, Max Super Specialty Hospital, Delhi, IndiaDepartment of Pediatrics, Dr. Wadhwa’s Clinic, New Delhi, IndiaDepartment of Paediatrics, Institute of Child Health, Kolkata, IndiaDepartment of Gastroenterology, Apollo Hospitals, Hyderabad, IndiaDepartment of Pediatrics, Vijay Marie Hospital, Hyderabad, IndiaDepartment of Paediatrics, KEM Hospital Research Centre, Pune, IndiaDepartment of Paediatrics, Institute of Child Health, Kolkata, IndiaWhile Hepatitis A Virus (HAV) vaccination in global immunization programs has shown a virtual elimination of the disease within few years of the vaccination program, changing epidemiological landscape in India underscores the need for evidence-based, updated guidance on immunization practices. In May 2024, a panel of 15 distinguished opinion leaders and an organizing committee convened for an intensive, face-to-face advisory board meeting on high burden of HAV infection among adults, increased mortality rate in adolescents, symptomatic presentation in children, and evolving landscape globally and within India. Extensive comparable deliberations on long-term follow-up data from India and data from country of origin advocated immunogenicity, tolerability, and long-term protective effects of single-dose live attenuated HAV vaccine in children. Finally, a consensus was achieved on recognition of increased global attention toward HAV prevention through vaccination coverage. The need for a single dose of live attenuated HAV vaccine was an important outcome of this meeting.https://www.tandfonline.com/doi/10.1080/21645515.2024.2447643Hepatitis Aimmunogenicitylive attenuated vaccinetolerabilitysafety
spellingShingle Nitin Shah
M.M.A. Faridi
Sheila Bhave
Apurba Ghosh
S. Balasubramanian
Vidya Arankalle
Raju Shah
Amar Jeet Chitkara
Arun Wadhwa
Jaydeep Chaudhry
Ramesh Srinivasan
M. Surendranath
Amita Sapru
Monjori Mitra
Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India
Human Vaccines & Immunotherapeutics
Hepatitis A
immunogenicity
live attenuated vaccine
tolerability
safety
title Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India
title_full Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India
title_fullStr Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India
title_full_unstemmed Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India
title_short Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India
title_sort expert consensus and recommendations on the live attenuated hepatitis a vaccine and immunization practices in india
topic Hepatitis A
immunogenicity
live attenuated vaccine
tolerability
safety
url https://www.tandfonline.com/doi/10.1080/21645515.2024.2447643
work_keys_str_mv AT nitinshah expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT mmafaridi expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT sheilabhave expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT apurbaghosh expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT sbalasubramanian expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT vidyaarankalle expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT rajushah expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT amarjeetchitkara expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT arunwadhwa expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT jaydeepchaudhry expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT rameshsrinivasan expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT msurendranath expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT amitasapru expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia
AT monjorimitra expertconsensusandrecommendationsontheliveattenuatedhepatitisavaccineandimmunizationpracticesinindia